Sitagliptin Shows Benefit in Diabetes Patients with COVID-19

Sitagliptin Shows Benefit in Diabetes Patients with COVID-19

Sitagliptin Shows Benefit in Diabetes Patients with COVID-19

The type 2 diabetes drug sitagliptin improves survival in patients with diabetes who have been hospitalized with COVID-19, according to Italian researchers. Patients who were given sitagliptin in addition to insulin had a mortality rate of 18 percent, versus 37 percent in similar patients who received insulin alone. Read more

Related

Via Source link